Implied equity duration as a measure of risk and its simultaneous endogeneity with performance in European companies
by Pedro Reis
International Journal of Economics and Business Research (IJEBR), Vol. 19, No. 3, 2020

Abstract: This work, in addition to applying the adapted implied equity duration (IED) concept through incorporating the dividends returned by the stock markets of France, Germany, Spain, Portugal and the UK, creates and tests new concepts both for firm risk and of business life expectancy, entitled the implied enterprise value duration (IEVD), for those countries. Furthermore, this article provides proof of the simultaneous endogeneity between IED and performance through recourse to a simultaneous equations system approach with 3sls and, additionally, studies the implications of company expected life, capital structure, size, market expectations, historic growth and risk both on IED and on performance. This paper reaches an IED based on dividends for European companies of 9.93 years, contributing to the existing IED paradox and confirming that IED is a risk measure. Furthermore, it concludes that IED does not provide a proxy for company life expectancy.

Online publication date: Thu, 09-Apr-2020

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Economics and Business Research (IJEBR):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com